The Integrated Training in Pharmacological Sciences program at Mount Sinai aims to provide rigorous interdisciplinary pre-doctoral training in the fundamental mechanisms that control physiological and pathophysiological processes and drug action. It is the goal of this program to provide educational activities and research training that connect the basic mechanistic findings to therapeutic modalities including the identification of drug targets and development of lead therapeutic compounds. The training program seeksto achieve in-depth training coupled with a broad perspective that equips the trainees to incorporate emerging new areas throughout their careers. The program also seeks to create a learning environment that promotes independent thinking and individual analytical skills, while fostering the ability to work in collaborative learning and research environments. The program combines a core of integrated didactic training in Pharmacology and Systems Biology that provides grounding in core principles of biochemistry, structural biology, genetics, cellular and molecular biology within a context of physiology and disease pathophysiology. Computational and modeling approaches to systems problems at various scales, to large data sets and to epidemiological problems are introduced throughout, together with support that enables students with different entering levels of quantitative skills to succeed. This curriculum uses an integrated active learning approach in both basic and advanced courses that is enhanced by specific pedagogical innovations. They include asynchronous discussions as well as in-class discussions and use of peer evaluation methodologies that prepare students for this major feature of their future careers. The 49 participating faculty of this training program are drawn from 13 academic departments and institutes that include a mix of clinical and basic science emphases. Their research projects provide opportunities for program trainees to tackle important problems in diverse areas of biomedicine that have strong pharmacological and/or systems biology interfaces and translational potential. The interdisciplinary and translational training environment and the structure of the program foster the entry of our trainees into independent scientific careers.

Public Health Relevance

Breakthroughs that yield new drugs that ameliorate different human diseases, that yield new diagnostics or new therapeutic strategies depend more and more upon researchers who apply quantitativecomputational methods to the complex biology of disease and drug interactions.
We aim to foster these skills in talented PhD and MD/PhD students, enabling them to achieve the next generation of breakthroughs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM062754-12
Application #
8288918
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
2001-07-05
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
12
Fiscal Year
2012
Total Cost
$267,782
Indirect Cost
$14,858
Name
Icahn School of Medicine at Mount Sinai
Department
Pharmacology
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Kim, S H; Steele, J W; Lee, S W et al. (2014) Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer A? oligomer mouse. Mol Psychiatry 19:1235-42
Steele, John W; Brautigam, Hannah; Short, Jennifer A et al. (2014) Early fear memory defects are associated with altered synaptic plasticity and molecular architecture in the TgCRND8 Alzheimer's disease mouse model. J Comp Neurol 522:2319-35
Bouhaddou, Mehdi; Birtwistle, Marc R (2014) Dimerization-based control of cooperativity. Mol Biosyst 10:1824-32
Bruns, Ingmar; Lucas, Daniel; Pinho, Sandra et al. (2014) Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion. Nat Med 20:1315-20
Smith, Steven G; Sanchez, Roberto; Zhou, Ming-Ming (2014) Privileged diazepine compounds and their emergence as bromodomain inhibitors. Chem Biol 21:573-83
Costa, Justin A; Nguyen, Dac A; Leal-Pinto, Edgar et al. (2013) Wicking: a rapid method for manually inserting ion channels into planar lipid bilayers. PLoS One 8:e60836
Lane, Rachel F; Steele, John W; Cai, Dongming et al. (2013) Protein sorting motifs in the cytoplasmic tail of SorCS1 control generation of Alzheimer's amyloid-? peptide. J Neurosci 33:7099-107
Zhao, Shan; Nishimura, Tomohiro; Chen, Yibang et al. (2013) Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med 5:206ra140
Na, Jianbo; Musselman, Laura Palanker; Pendse, Jay et al. (2013) A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet 9:e1003175
Golden, Sam A; Christoffel, Daniel J; Heshmati, Mitra et al. (2013) Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med 19:337-44

Showing the most recent 10 out of 50 publications